Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.

MLA

Dong, H. Y., et al. “Therapeutic Drug Monitoring and Receiver Operating Characteristic Curve Prediction May Reduce the Development of Linezolid-Associated Thrombocytopenia in Critically Ill Patients.” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 33, no. 6, June 2014, pp. 1029–35. EBSCOhost, https://doi.org/10.1007/s10096-013-2041-3.

APA

Dong, H.-Y., Xie, J., Chen, L.-H., Wang, T.-T., Zhao, Y.-R., & Dong, Y.-L. (2014). Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 33(6), 1029–1035. https://doi.org/10.1007/s10096-013-2041-3

Chicago

Dong, H-Y, J Xie, L-H Chen, T-T Wang, Y-R Zhao, and Y-L Dong. 2014. “Therapeutic Drug Monitoring and Receiver Operating Characteristic Curve Prediction May Reduce the Development of Linezolid-Associated Thrombocytopenia in Critically Ill Patients.” European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 33 (6): 1029–35. doi:10.1007/s10096-013-2041-3.